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1118-83 Pathological Features Found Postmortem in 53 Patients 
With Cardiac Rupture Complicating Acute Myocardial 
Infarction
Satoshi Yasuda, Yasuhide Asaumi, Hiroyuki Okumura, Yoritaka Otsuka, Isao Morii, 
Atsushi Kawamura, Chikao Yutani, Hiroshi Nonogi, Shunichi Miyazaki, National 
Cardiovascular Center, Osaka, Japan
Background: Cardiac rupture is responsible for about 15% of all in-hospital deaths
among patients with acute myocardial infarction (AMI). However, information regarding
the clinical profile and pathological features of this fatal complication is limited.
Methods: We studied 53 consecutive patients with AMI (M/F; 32/21, age; 73±7
[mean±SD] years), who died of ventricular septal and free wall rupture between 1978 and
2002. The diagnosis was made based on postmortem histological examination. Forty-
two patients (80%) were without previous infarction and 44 patients (84%) were hyper-
tensive.
Results: Cardiac rupture occurred acutely within 48 hours of AMI onset in 20 patients
(38%). Also, it occurred 6-8 days after the onset of AMI in 17 patients (32%), in whom
immunohistochemical studies revealed accumulation of inflammatory cells and activation
of matrix metalloproteinases at the rupture site. AMI-related artery was the left anterior
descending artery in 37 patients (70%), the right coronary artery in 13 patients (25%)
and the left circumflex artery in 3 patients (5%). In most patients (n=48, 91%), the AMI-
related vessel was totally or subtotally occluded. Since 1993, the era in which the reper-
fusion therapy has been developed, the total number of rupture patients has been
decreasing, but the percentage of those with hemorrhagic infarction has been increasing;
1978–82, n=12 (17%); 1983-87, n=14 (29%); 1988-92, n=14 (36%); 1993-97, n=7 (57%);
1998-2002, n=6 (50%).
Conclusions: These findings indicate the potential importance of revascularization of
the AMI-related artery to reduce the risk of cardiac rupture. Histologically, sustained
inflammatory responses with metalloprotease activation may contribute to modulating the
wound-healing process following infarction.
1118-84 Is the Timing of Coronary Artery Bypass Graft Surgery 
Following Acute Myocardial Infarction Associated With 
a Difference in Mortality?
Michael Mack, Marc Katz, Aaron Kugelmass, J. James Zocco, Timonthy Wolfgang, 
Thomas Christopher, Edmund Becker, Steven Culler, April Simon, Emory University, 
Atlanta, GA, CRSTI, Dallas, TX
Background: This study examines association between operative and predicted mortal-
ity rates and the length of time between a preoperative myocardial infarction (MI) and cor-
onary artery bypass graft surgery (CABG) in patients treated in community hospitals.
Methods: The study sample consists of 5,465 consecutive patients who underwent
CABG only in one of 18 community hospitals. Logistic regression analysis was utilized to
determine if selected time intervals ( 21 days) between a preoperative MI and CABG
were statistically associated with operative mortality after controlling for 30 demographic,
procedural and cardiac risk factors.
Results: Approximately 42% of the sample had an MI prior to CABG. Patient’s whose
CABG was performed within the first 24 hours had significantly higher mortality rates
than those observed for patients whose CABG was delayed by at least 24 hours (see
table). Controlling for demographic, procedural and cardiac risk factors, patient’s whose
CABG was performed within the first 24 hours were 2.7 times (p=0.024) more likely to die
during their hospitalization than patients having surgery between 1 and 7 days after their
MI.
Conclusions: Operative mortality is highest if CABG is performed within the first 24 hrs
of MI, but there is no difference between any of the other MI groups (1-7 days, 8-21 days,
or > 21 days). Further research needs to assess the clinical imperative for surgery within
the first 24 hrs. 
1118-101 Congestive Heart Failure and Cardiogenic Shock 
Complicating Acute Myocardial Infarction Have High 
Mortality and Are Associated With Intense Inflammatory 
Response: Results From the CARDINAL Trials
Rafael Valencia, Pierre Theroux, Christopher B. Granger, Kenneth W. Mahaffey, Taissa 
Gudaye, Kevin Malloy, W. Douglas Weaver, Thomas G. Todaro, Christopher F. Mojcik, 
Paul W. Armstrong, Judith S. Hochman, New York University Medical Center, New York, 
NY
There are limited data on the development, clinical correlates, role of inflammation and
outcomes of CHF and cardiogenic shock (CS) complicating acute ST-elevation MI
(STEMI) in the reperfusion era.
We analyzed data from The Complement and ReDuction of Infarct size after Angioplasty
or Lytics (CARDINAL) program which included fibrinolytic and primary percutaneous cor-
onary intervention (PCI) trials investigating adjunctive pexelizumab, a monoclonal anti-
body against C5 complement, in the management of STEMI. The characteristics and
outcomes of 1903 enrolled patients and a subset of 350 PCI patients with serial inflam-
matory markers and proBNP levels were evaluated.
New or worsening CHF or CS developed in 3% and 4% of patients respectively. Patients
who developed CHF or CS presented with a greater prevalence of diabetes mellitus
(p=0.003). There was an association of increasing heart rate (p<0.001) and decreasing
systolic blood pressure (p<0.001) on presentation and increasing infarct size (area under
the curve for CK MB thru 72 hrs) (p<0.001) with the development of CHF or CS. White
blood cell count at presentation was higher in the group that developed CS (p=0.006).
Higher levels of IL-6, TNF alpha, hsCRP, and proBNP were seen in patients who pre-
sented in CHF or CS. Patients who presented to the hospital without CHF or CS but later
developed new CS had significantly higher levels of IL-6, TNF alpha, and proBNP at pre-
sentation, 24 hours and 72 hours after presentation compared to patients who did not
develop CS. The most striking difference was seen with IL-6 with average values at time
0, 24 and 72 hours of 19, 367, and 199 pg/mL in patients who presented without CHF or
CS but developed new CS compared to patients who did not develop CS whose values
were 11, 50, and 29 pg/mL respectively (p<0.001). Mortality in patients who developed
CS was 61% compared with 13% in patients who developed CHF and 5% in patients
without the development of CHF or CS (p<0.001).
Despite reperfusion therapy, CHF and CS continue to complicate acute STEMI and are
associated with high mortality rates. CHF and to a larger extent, CS, are associated with
a marked inflammatory response which has potential diagnostic and therapeutic implica-
tions.
1118-102 Baseline White Blood Cell Count and Interleukin-6 
Levels Provide Complementary Prognostic Information 
in Acute Myocardial Infarction: Results From the 
CARDINAL Trial
Manesh R. Patel, Kenneth W. Mahaffey, Paul W. Armstrong, W. Douglas Weaver, Gudaye 
Tasissa, Judith S. Hochman, Thomas G. Todaro, Kevin J. Malloy, Thomas H. Parish, 
Scottt Rollins, Pierre Theroux, Wiltold Ruzyllo, Jose C. Nicolau, Christopher B. Granger, 
Duke Clinical Research Institute, Durham, NC
Background: Inflammation plays an important role in pathophysiology of acute coronary
syndromes.
Methods: The relationships between baseline WBC count, interleukin-6 (IL6) levels in a
subset of patients (n=328), and their association with outcomes were analyzed using
data from two trials in the CARDINAL program evaluating pexelizumab (antibody to com-
plement factor C5) in patients with ST elevation myocardial infarction undergoing fibrinol-
ysis (n=934) or primary PCI (n=960). Infarct sizes determined by CKMB area under the
curve and 90-day mortality were analyzed.
Results: Higher WBC counts (highest quartile vs. lowest quartile) at presentation were
associated with younger age (median 56 vs. 62 years), higher proportion of anterior inf-
arcts (82.9% vs. 76.9%), and higher proportion with Killip Class > 1 (22.6% vs. 11.2%)
respectively. Higher WBC count was also associated with larger infarct size (CKMB 5690
vs. 2882 [ng/mL] • h) and development of congestive heart failure and shock (6.6% vs.
2.6%). Mortality at 90-days was significantly related to WBC count (figure, p
value=0.017). Median IL-6 levels tracked with baseline WBC count, highest vs. lowest
quartile(Q4-16 ng/dl vs.Q1-8.3ng/dl IL-6), and subsequent outcomes.
Conclusion: WBC count was directly related to infarct size and mortality. A marker of
inflammation, IL-6 tracked with WBC count and outcomes. The baseline WBC count is a
simple marker of inflammation that provides prognostic information. 
Mortality Rates From Time of MI to CABG
No MI < 24 Hrs. 1-7 Days 8-21 Days > 21 Days
Patients 3,213 103 957 217 975
Operative Mortality 1.7% 19.4% 3.7% 2.8% 3.3%
Predicted Mortality 2.1% 10.7% 4.0% 4.9% 3.3%
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Chronic Cardiac Ischemic Syndromes: 
Gender Considerations, Markers, and 
Mechanisms
Tuesday, March 09, 2004, 9:00 a.m.-11:00 a.m.
Morial Convention Center, Hall G
Presentation Hour: 9:00 a.m.-10:00 a.m.
1119-93 Any Measurable Coronary Artery Disease Identified in 
Women Presenting With Ischemic Chest Pain Is 
Associated With an Adverse Outcome: Findings From 
the National Institutes of Health-National Heart, Lung, 
and Blood Institute-Sponsored Womens Ischemia 
Syndrome Evaluation (WISE) Study Angiographic Core 
Laboratory
Barry L. Sharaf, Leslee Shaw, B. Delia Johnson, Sheryl F. Kelsey, Marian B. Olson, Sunil 
Mankad, William J. Rogers, Steven E. Reis, Carl J. Pepine, C. Noel Bairey Merz, Rhode 
Island Hospital, Providence, RI
Background: Minimal (Min) or non-obstructive coronary artery disease (CAD) is often
identified in women presenting with a suspicion of ischemic chest pain. Whether or not
this Min CAD is associated with an adverse outcome has not been well studied.
Methods: Accordingly, angiograms from 887 women undergoing clinically indicated cor-
onary angiography were analyzed by core laboratory for the presence of CAD. No CAD
(<20% stenosis), Min CAD (>20, <50%) and obstructive CAD (>50% stenosis) was iden-
tified in 37, 25, and 38% of women. A severity score (SS) was developed which assigned
points for any CAD (>20% stenosis) weighted by stenosis severity, location and collater-
als. A SS of 5 was assigned to those women with no CAD. Most (71%) women with Min
CAD had SS between 5.1 and 10. SS >50 represents severe, diffuse 3 vessel obstructive
CAD.
Results: The average age of the women presenting was 58yrs, with 25% diabetic.
Twenty percent were non-Caucasian. Death or MI at 3 yrs occurred in 1.9, 3.8 and 8.4%
of women with no, Min and obstructive CAD (p<0.0001). Death or MI rates by angio-
graphic severity score (figure) at 3 yrs of follow-up were 2.1, 6, 7.7, 9.3 and 12.4% for
those women with SS =5, 5.1-10, 10.1-20, 20.1-50 and >50 (p<0.0001).
Conclusions: CAD associated adverse outcome is identified even in those women with-
out obstructive lesions. Whether adverse outcome in these women with Min CAD is due
to endothelial or microvascular dysfunction or rupture of vulnerable, non-obstructive
plaque is unknown and deserves further study. 
1119-94 Reduced Functional Capacity in Women Is Associated 
With Impaired Vascular Function
Eileen Handberg, B. Delia Johnson, Christopher B. Arant, Timothy R. Wessel, Marian B. 
Olson, Steven E. Reis, Leslee Shaw, Sunil Mankad, William J. Rogers, C. Noel Bairey 
Merz, George Sopko, Carl J. Pepine, The WISE Investigators, University of Florida, 
Gainesville, FL, University of Pittsburgh, Pittsburgh, PA
Background: Reduced functional capacity is associated with poor prognosis, but the
basis for this link is not well understood in patients without heart failure. The Duke Activity
Status Index (DASI) is a validated assessment of functional capacity which has been cor-
related with outcome. Impaired vascular reactivity has also been associated with poor
prognosis. We examined the relationship of vascular reactivity and DASI scores in a
cohort of women enrolled in the NHLBI-WISE.
Methods: We examined DASI scores in 203 women with coronary flow reserve (CFR) to
adenosine assessments and 381 women with brachial artery flow mediated dilation
(FMD) assessments. DASI scores were converted to metabolic equivalents (MET).
Results: The mean age of all women was 57 + 11 (21-83), 14% were non-white, 40% had
a BMI > 30, and 32% had CAD (> 50% stenosis). Women with a CFR of <2.5 (n=97) had
a mean MET level of 4.8 + 4.1, compared to 6.5 + 4.9 in those women (n=106) with CFR
> 2.5 (p=0.009). Women with both CFR and FMD (n=83) are shown below, with p-value
(0.006) adjusted for age and presence of CAD.
Summary: Women with a CFR< 2.5 were significantly more likely to have a functional
impairment (a low DASI score), and women with both reduced CFR and FMD had the
lowest DASI scores (~ 3 METs). Impairment in vascular function may result in modifica-
tion of activity status and may help to explain poorer prognosis seen in women with
reduced functional capacity who are evaluated for suspected ischemia.
1119-95 N-Terminal-Pro Braintype Natriuretic Peptide Predicts 
Extent of Coronary Artery Disease and Myocardial 
Ischemia in Patients With Stable Angina Pectoris
Michael W. Weber, Roman Arnold, Torsten Dill, Matthias Rau, Vesselin Mitrovic, Klaus D 
Mueller, Christian Hamm, Kerckhoff Heart Center, Bad Nauheim, Germany
Background:. Recently its has been shown, that BNP and NT-proBNP are good predic-
tors for prognosis in acute coronary syndromes (STEMI and NSTEMI) and that NT-
proBNP increases after transient myocardial ischemia during coronary angioplasty.
Hypothesis: NT-proBNP is elevated in patients with stable angina pectoris and hemody-
namically relevant coronary artery disease (CAD) with exercise induced ischemia.
Methods: 94 patients (71 male, aged 62,3±8,7) with normal left ventricular function
referred for coronarangiography with suspected CAD were included. All patients under-
went exercise testing, coronarangiography and myocardial scintigraphy (n=91). Blood for
measurement of NT-proBNP was taken before and 15 minutes after maximal exercise.
Values are given as mean ± SEM.
Results: 58 patients had a hemodynamically relevant CAD (> 1 vessel with a stenosis >
70%) and in 52 patients ischemia was detected by myocardial scintigraphy. NT-proBNP
was elevated in patients with CAD (386±72 pg/ml vs. 148±29 pg/ml respectively ; p<0,01
Mann Whitney) and in patients with myocardial ischemia (396±80 pg/ml vs. 160±27 pg/
ml respectively; p=0,01; Mann Whitney). The increase in NT-proBNP correlated with the
number of stenosed vessels (3VD 624±186 pg/ml; 1/2VD 269±5 pg/ml; no CAD 148±29
pg/ml; p<0,01 Kruskal Wallis). There was no increase after maximal exercise in patients
with CAD (386±72 pg/ml respectively 393±74 pg/ml; n.s.). ROC curve analyses for NT-
proBNP as predictor for hemodynamically relevant CAD showed an AUC of 0,72
(p<0,01). Using an optimised cut-off level for NT-proBNP of 214 pg/ml we found a sensi-
tivity of 55%, a specificity of 78%, a NPV of 54%, a PPV of 84% and a total test efficiency
of 1,38. Adding NT-proBNP to exercise testing, CAD can be predicted with higher accu-
racy (sensitivity 83%, specificity 69%, NPV 71%, PPV 81% and total test efficiency 1,52)
Conlusions: NT-proBNP is elevated in patients with stable angina pectoris with a strong
correlation to the extend of coronary artery disease and myocardial ischemia. Combining
NT-proBNP with exercise testing the accuracy for predicting CAD can be improved.
Therefore NT-proBNP is of attributable value in the diagnostic process of stable angina
pectoris.
